<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02344251</url>
  </required_header>
  <id_info>
    <org_study_id>PRO00033472</org_study_id>
    <nct_id>NCT02344251</nct_id>
  </id_info>
  <brief_title>Assessing the Effectiveness and Safety of the ID-Cap System for Medication Monitoring and Adherence</brief_title>
  <official_title>A Phase II Randomized Trial to Assess the Effectiveness and Safety of the ID-Cap System for Medication Ingestion Monitoring and Enhancing Adherence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of South Carolina</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In pharmacotherapy trials involving drug-dependent individuals, medication compliance is a
      significant issue, as rates tend to be low and adherence to medication may predict improved
      outcomes (Baros et al, 2007; McRae et al, 2004; O'Brien et al, 1996; Somoza et al., 2010).
      However, methods commonly used to determine compliance may result in inaccurate measurement
      of adherence. In this study, we propose to assess the effectiveness and safety of the ID-Cap
      System, a novel compliance measurement device, in a healthy population.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of this clinical trial is to evaluate the acceptability, tolerability,
      and efficacy of the ID-Cap system in a healthy population. The ID-Cap is an ingestible
      medical device for detecting the presence of an ingested capsule inside the gastrointestinal
      (GI) tract.

      Participation in the study takes 3 visits over a period of approximately six weeks. The first
      visit is a screening visit to determine if participants are eligible to participate. After
      the initial assessment visit, participants will be randomized to one of two groups. Group 1
      will have adherence measured by self-report, pill count, and urine riboflavin levels. This
      group will not receive capsules containing ingestible sensors, but will receive their
      medication in a bottle capped with a MEMS Track Cap, which records when the medication bottle
      is opened and closed. Group 2 will receive capsules containing an ingestible sensor and will
      have adherence measured by self-report, pill count, urine riboflavin levels as needed, and
      data collected by an ID-Cap reader. Participants randomized to this group will also receive
      reminder calls and/or text messages to ingest the study medication if a signal is not sent
      from the ID-Cap reader to the study team within one hour of the scheduled medication
      administration time. They will also be using biometric identification technology to confirm
      subject identity, specifically electrocardiogram (ECG).

      After the initial screening visit, participants will be required to attend two clinic visits
      during the six-week study, a randomization visit and a one-week follow-up visit approximately
      one week after last medication dose.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2016</start_date>
  <completion_date type="Actual">December 1, 2017</completion_date>
  <primary_completion_date type="Actual">December 7, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Medication Adherence</measure>
    <time_frame>30 days</time_frame>
    <description>The primary outcome will be medication adherence as measured by percentage of doses taken among groups.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety Assessment: Rates of Adverse Events Reported</measure>
    <time_frame>30 days</time_frame>
    <description>A secondary outcome will be safety assessment as measured by the percentage of participants reporting adverse events.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Medication Adherence</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Adherence measured by MEMS Cap</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Adherence measured by ID-Cap technology.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MEMS Cap</intervention_name>
    <description>MEMS Track Cap records when the medication bottle is opened and closed</description>
    <arm_group_label>Group 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ID-Cap</intervention_name>
    <description>ID-Cap Tag is an ingestible medical device for detecting the presence of an ingested capsule inside the gastrointestinal (GI) tract.</description>
    <arm_group_label>Group 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Must be between the ages of 18 and 65 years

          -  If female and of childbearing potential, must agree to use acceptable methods of birth
             control for the duration of the trial

          -  Must consent to random assignment, and be willing to commit to medication ingestion

          -  Must be able to read and provide informed consent

          -  Must function at an intellectual level sufficient to allow accurate completion of
             assessments

          -  Must have a Body Mass Index (BMI) below 35

        Exclusion Criteria:

          -  Women who are pregnant, nursing, or plan to become pregnant during the course of the
             study

          -  Must not have evidence of a significant medical condition which may affect capsule
             passage through the gastrointestinal tract (including, but not limited to, Crohn's
             disease, small bowel tumors, intestinal adhesions, ulcerations, and radiation
             enteritis)

          -  Must not have a current major psychiatric disorder as these may interfere with
             assessment measures

          -  Must not be currently dependent on other substances, with the exception of nicotine or
             caffeine, within the past 60 days

          -  Hypersensitivity to riboflavin or any capsule component;

          -  Individuals with embedded electronic devices

          -  Patients who, in the investigator's opinion, would be unable to comply with study
             procedures or assessments, or would be unacceptable study candidates (e.g., poses
             threat to staff)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aimee McRae-Clark, PharmD, BCPP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 16, 2015</study_first_submitted>
  <study_first_submitted_qc>January 21, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 22, 2015</study_first_posted>
  <results_first_submitted>February 22, 2018</results_first_submitted>
  <results_first_submitted_qc>February 22, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">March 20, 2018</results_first_posted>
  <last_update_submitted>March 30, 2018</last_update_submitted>
  <last_update_submitted_qc>March 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of South Carolina</investigator_affiliation>
    <investigator_full_name>Aimee McRae-Clark</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Drug study</keyword>
  <keyword>Medication compliance</keyword>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>MEMS Track Cap</title>
          <description>Compliance measured by MEMS Cap, riboflavin and self-report.
MEMS Cap: MEMS Track Cap records when the medication bottle is opened and closed
Riboflavin: 50 mg</description>
        </group>
        <group group_id="P2">
          <title>ID Cap Tag</title>
          <description>Compliance measured by riboflavin, self-report, and ID-Cap technology.
ID-Cap: ID-Cap Tag is an ingestible medical device for detecting the presence of an ingested capsule inside the gastrointestinal (GI) tract.
Riboflavin: 50 mg</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Group 1</title>
          <description>Compliance measured by MEMS Cap
MEMS Cap: MEMS Track Cap records when the medication bottle is opened and closed</description>
        </group>
        <group group_id="B2">
          <title>Group 2</title>
          <description>Compliance measured by ID-Cap technology
ID-Cap: ID-Cap Tag is an ingestible medical device for detecting the presence of an ingested capsule inside the gastrointestinal (GI) tract.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="20"/>
            <count group_id="B3" value="40"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Medication Adherence</title>
        <description>The primary outcome will be medication adherence as measured by percentage of doses taken among groups.</description>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>MEMS Track Cap</title>
            <description>Adherence measured by MEMS Cap
MEMS Cap: MEMS Track Cap records when the medication bottle is opened and closed</description>
          </group>
          <group group_id="O2">
            <title>ID Cap</title>
            <description>Adherence measured by ID-Cap technology.
ID-Capsule: ID-Capsule is an ingestible medical device for detecting the presence of an ingested capsule inside the gastrointestinal (GI) tract.</description>
          </group>
        </group_list>
        <measure>
          <title>Medication Adherence</title>
          <description>The primary outcome will be medication adherence as measured by percentage of doses taken among groups.</description>
          <units>percentage of doses taken</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94.8" lower_limit="92.2" upper_limit="97.3"/>
                    <measurement group_id="O2" value="82.8" lower_limit="76.4" upper_limit="89.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Safety Assessment: Rates of Adverse Events Reported</title>
        <description>A secondary outcome will be safety assessment as measured by the percentage of participants reporting adverse events.</description>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>MEMS Track Cap</title>
            <description>Compliance measured by MEMS Cap
MEMS Cap: MEMS Track Cap records when the medication bottle is opened and closed</description>
          </group>
          <group group_id="O2">
            <title>ID Cap</title>
            <description>Compliance measured by ID-Cap technology.
ID-Cap: ID-Cap Tag is an ingestible medical device for detecting the presence of an ingested capsule inside the gastrointestinal (GI) tract.</description>
          </group>
        </group_list>
        <measure>
          <title>Safety Assessment: Rates of Adverse Events Reported</title>
          <description>A secondary outcome will be safety assessment as measured by the percentage of participants reporting adverse events.</description>
          <units>percentage of participants reporting AEs</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                    <measurement group_id="O2" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>4 week medication period</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Group 1</title>
          <description>Compliance measured by MEMS Cap
MEMS Cap: MEMS Track Cap records when the medication bottle is opened and closed</description>
        </group>
        <group group_id="E2">
          <title>Group 2</title>
          <description>Compliance measured by ID-Cap technology.
ID-Cap: ID-Cap Tag is an ingestible medical device for detecting the presence of an ingested capsule inside the gastrointestinal (GI) tract.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Food poisoning</sub_title>
                <description>exact symptom(s) not detailed in AE report</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>weight gain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Ringworm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Increased urination</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cold</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Limited generalizability- participants were primarily MUSC students &amp; staff. The ID Cap system is only available for adherence measurement for solid oral dosage medications. Potential for user error due to the electronic nature of the ID Cap system.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Aimee McRae-Clark</name_or_title>
      <organization>MUSC</organization>
      <email>mcraeal@musc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

